Joint Clinical Trials Office

You are here

News

Dr. Peter Martin
Dr. Peter Martin

Improving the odds for people with Non-Hodgkin Lymphoma

Thousands of people living with, or recovering from, non-Hodgkin lymphoma (NHL) will benefit from an $11 million boost from the National Cancer Institute to support a multi-institutional investigation into their current and long-term unmet healthcare needs. 

Peter Martin, M.D.,  the Charles, Lillian, and Betty Neuwirth Clinical Scholar in Oncology and assistant professor of medicine, will be overseeing the recruitment of participants and...

Read More
Veins in the head, artwork Credit: Getty Images
Veins in the head, artwork Credit: Getty Images

Bacterial Endocarditis Increases Stroke Risk for Longer Period than Previously Reported

Patients who develop an infection of the heart valves, known as bacterial endocarditis, have an elevated risk of stroke beginning four months before and up to five months after diagnosis — a period significantly longer than previously reported, researchers from Weill Cornell Medical College and NewYork-Presbyterian Hospital found in a new study, published July 10...

Read More
Dr. Louis Aronne
Dr. Louis Aronne

Food Order Has Significant Impact on Glucose and Insulin Levels

Eating protein and vegetables before carbohydrates leads to lower post-meal glucose and insulin levels in obese patients with type 2 diabetes, Weill Cornell Medical College researchers found in a new study. This finding, published June 23 in the journal Diabetes Care, might impact the way clinicians advise diabetic patients and other high-...

Read More
Dr. Laurie H. Glimcher
Dr. Laurie H. Glimcher

Weill Cornell Investigators Discover How Ovarian Cancer Halts Body's Natural Defense Against Tumor

Ovarian cancer shuts down immune system cells that would otherwise act as a first line of defense against the deadly tumor, Weill Cornell Medical College scientists report today. But a therapy that restores the cells' disease-fighting abilities could provide a powerful new strategy to attack the cancer, which kills more than 14,000 women each year.

In the June 11 issue of Cell, the investigators...

Read More
Dr. James K. Min
Dr. James K. Min

Weill Cornell Researchers Improve Risk Assessment for Stable Patients with Suspected Heart Disease

Using basic information like age, gender and clinical history, Weill Cornell Medical College researchers have developed a simple method to more accurately predict whether a stable patient is likely to suffer from coronary artery disease or die of a heart attack in the next three years.

Cardiologists often use algorithms to determine whether or not patients should undergo invasive testing. With this easy-to-use, accurate method to determine risk, they can...

Read More

Researcher's Toolbox

Contact Information

Joint Clinical Trials Office Weill Cornell Medicine /
NewYork-Presbyterian
1300 York Avenue,
Box 305
New York, NY 10065 Phone: (646) 962-8215 Fax: (646) 962-0536

Abbreviation Library